Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rankning i aktier #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aktiekurs
$29.86
Senast synkroniserad: 2026-08-19
Marknadsvärde
$2.48B
Förändring (1 dag)
4.92%
Förändring (1 år)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategori

Aktiekurshistorik för Lin BioScience, Inc. (6696)
Högsta slutkurs: $26.88 den 2026-08-01

Lägsta slutkurs: $1.30 den 2018-10-01
Aktiekurshistorik för Lin BioScience, Inc. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$543.30 39.64%
US
$1.05K 47.66%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$761.61 6.68%
CH